{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T13:19:17Z","timestamp":1740143957877,"version":"3.37.3"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,3,13]],"date-time":"2024-03-13T00:00:00Z","timestamp":1710288000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,3,13]],"date-time":"2024-03-13T00:00:00Z","timestamp":1710288000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100008001","name":"Universit\u00e4t zu K\u00f6ln","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100008001","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Res Cardiol"],"published-print":{"date-parts":[[2025,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>The cryoballoon (CB) has become a standard tool for pulmonary vein isolation (PVI), but the technology is limited in certain ways. A novel RF-balloon (Heliostar\u2122, Biosense Webster, CA, USA) promises the advantages of a balloon technology in combination with 3D mapping.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>To assess procedural data and outcome, all patients undergoing RF-balloon PVI were included and compared with data from consecutive patients undergoing CB PVI for paroxysmal AF.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>A total of 254 patients (63\u2009\u00b1\u200913\u00a0years, 54% male) were included: 30 patients undergoing RF-balloon and 224 patients CB PVI. Baseline parameters were comparable. Procedure duration (104.3\u2009\u00b1\u200935.3\u00a0min vs. 69.9\u2009\u00b1\u200923.1\u00a0min; <jats:italic>p<\/jats:italic>\u2009\u2264\u20090.001) and fluoroscopy time (16.3\u2009\u00b1\u20097.1\u00a0min vs. 11.6\u2009\u00b1\u20094.9\u00a0min; <jats:italic>p<\/jats:italic>\u2009\u2264\u20090.001) were longer using the RF-balloon; ablation time (43.5\u2009\u00b1\u200917.9 vs. 36.4\u2009\u00b1\u200915.6; <jats:italic>p<\/jats:italic>\u2009=\u20090.08) did not differ, and time-to-isolation (TTI) was shorter (18.2\u2009\u00b1\u20097.0\u00a0s vs. 62.8\u2009\u00b1\u200935.1\u00a0s; <jats:italic>p<\/jats:italic>\u2009\u2264\u20090.001). Second-generation RF-balloon cases showed shorter ablation time and TTI at comparable procedure duration and fluoroscopy time. One pericardial effusion occurred with the RF-balloon due to complicated transseptal access. During CB PVI in 4\/224 patients (1.8%), a phrenic nerve palsy was observed. After 12\u00a0months, 78% of patients after RF-balloon and 81% of patients after CB PVI (<jats:italic>p<\/jats:italic>\u2009=\u20090.5) were free from atrial arrhythmias.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>The RF-balloon was safe and effective. Compared with the CB, TTI was shorter, but procedure durations and fluoroscopy times were longer. This can be attributed to a learning curve and the initial necessity for separate 3D map preparation. Considering the results with the second-generation RF-balloon, more experience is needed to determine the potential benefits.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Graphical Abstract<\/jats:title>\n          <\/jats:sec>","DOI":"10.1007\/s00392-024-02401-w","type":"journal-article","created":{"date-parts":[[2024,3,13]],"date-time":"2024-03-13T08:55:41Z","timestamp":1710320141000},"page":"93-102","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Balloon technologies for pulmonary vein isolation\u201412-month outcome and comparison of the novel radiofrequency balloon with the cryoballoon in patients with paroxysmal atrial fibrillation"],"prefix":"10.1007","volume":"114","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0468-4887","authenticated-orcid":false,"given":"Jan-Hendrik","family":"van den Bruck","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2213-8946","authenticated-orcid":false,"given":"Jonas","family":"W\u00f6rmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1807-4860","authenticated-orcid":false,"given":"Arian","family":"Sultan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karlo","family":"Filipovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6346-7500","authenticated-orcid":false,"given":"Katharina","family":"Seuthe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susanne","family":"Erlh\u00f6fer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7054-3535","authenticated-orcid":false,"given":"Cornelia","family":"Scheurlen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sebastian","family":"Dittrich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0208-3295","authenticated-orcid":false,"given":"Jan-Hendrik","family":"Schipper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4667-2200","authenticated-orcid":false,"given":"Jakob","family":"L\u00fcker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6839-5895","authenticated-orcid":false,"given":"Daniel","family":"Steven","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,3,13]]},"reference":[{"key":"2401_CR1","first-page":"1","volume":"2020","author":"G Hindricks","year":"2020","unstructured":"Hindricks G, Potpara T, Dagres N, Arbelo E, Bax JJ, Blomstr\u00f6m-Lundqvist C et al (2020) ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 2020:1\u2013126","journal-title":"Eur Heart J"},{"key":"2401_CR2","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1056\/NEJMoa2029980","volume":"384","author":"JG Andrade","year":"2021","unstructured":"Andrade JG, Wells GA, Deyell MW, Bennett M, Essebag V, Champagne J et al (2021) Cryoablation or drug therapy for initial treatment of atrial fibrillation. N Engl J Med 384:305\u2013315","journal-title":"N Engl J Med."},{"key":"2401_CR3","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1056\/NEJMoa2029554","volume":"384","author":"OM Wazni","year":"2021","unstructured":"Wazni OM, Dandamudi G, Sood N, Hoyt R, Tyler J, Durrani S et al (2021) Cryoballoon ablation as initial therapy for atrial fibrillation. N Engl J Med 384:316\u2013324","journal-title":"N Engl J Med."},{"key":"2401_CR4","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.1056\/NEJMoa1602014","volume":"374","author":"KH Kuck","year":"2016","unstructured":"Kuck KH, Brugada J, F\u00fcrnkranz A, Metzner A, Ouyang F, Chun J et al (2016) Cryoballoon or radiofrequency ablation for paroxysmal atrial fibrillation. N Engl J Med 374:2235\u20132245","journal-title":"N Engl J Med"},{"key":"2401_CR5","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1016\/j.amjcard.2020.01.016","volume":"125","author":"F Fortuni","year":"2020","unstructured":"Fortuni F, Casula M, Sanzo A, Angelini F, Cornara S, Somaschini A et al (2020) Meta-analysis comparing cryoballoon versus radiofrequency as first ablation procedure for atrial fibrillation. Am J Cardiol 125:1170\u20131179","journal-title":"Am J Cardiol [Internet]."},{"key":"2401_CR6","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1111\/jce.14476","volume":"31","author":"GS Dhillon","year":"2020","unstructured":"Dhillon GS, Honarbakhsh S, Di Monaco A, Coling AE, Lenka K, Pizzamiglio F et al (2020) Use of a multi-electrode radiofrequency balloon catheter to achieve pulmonary vein isolation in patients with paroxysmal atrial fibrillation: 12-month outcomes of the RADIANCE study. J Cardiovasc Electrophysiol 31:1259\u20131269","journal-title":"J Cardiovasc Electrophysiol"},{"key":"2401_CR7","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1093\/europace\/euaa382","volume":"23","author":"R Schilling","year":"2021","unstructured":"Schilling R, Dhillon GS, Tondo C, Riva S, Grimaldi M, Quadrini F et al (2021) Safety, effectiveness, and quality of life following pulmonary vein isolation with a multi-electrode radiofrequency balloon catheter in paroxysmal atrial fibrillation: 1-year outcomes from SHINE. Europace 23:851\u2013860","journal-title":"Europace"},{"issue":"6","key":"2401_CR8","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1111\/jce.15799","volume":"34","author":"V Kanthasamy","year":"2023","unstructured":"Kanthasamy V, Breitenstein A, Schilling R, Hofer D, Tiongco B, Ang R et al (2023) Catheter ablation of atrial fibrillation with a multi-electrode radiofrequency balloon; first and early two centre experience in Europe. J Cardiovasc Electrophysiol 34(6):1350\u20131359","journal-title":"J Cardiovasc Electrophysiol"},{"key":"2401_CR9","first-page":"896","volume":"25","author":"A Del Monte","year":"2023","unstructured":"Del Monte A, Almorad A, Pannone L, Della Rocca DG, Bisignani A, Monaco C et al (2023) Pulmonary vein isolation with the radiofrequency balloon catheter: a single centre prospective study. Europace 25:896\u2013904\u00a0","journal-title":"EP Eur [Internet]."},{"key":"2401_CR10","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1007\/s10840-021-01094-9","volume":"64","author":"A Almorad","year":"2022","unstructured":"Almorad A, Chierchia GB, Pannone L, Osorio TG, Sorgente A, Bisignani A et al (2022) The optimized clinical workflow for pulmonary vein isolation with the radiofrequency balloon. J Interv Card Electrophysiol 64:531\u2013538","journal-title":"J Interv Card Electrophysiol [Internet]"},{"key":"2401_CR11","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1007\/s10840-022-01210-3","volume":"65","author":"C Scheurlen","year":"2022","unstructured":"Scheurlen C, van den Bruck JH, Filipovic K, W\u00f6rmann J, Arica Z, Erlh\u00f6fer S et al (2022) Procedural and outcome impact of obesity in cryoballoon versus radiofrequency pulmonary vein isolation in atrial fibrillation patients. J Interv Card Electrophysiol 65:403\u2013410","journal-title":"J Interv Card Electrophysiol [Internet]."},{"key":"2401_CR12","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1161\/CIRCULATIONAHA.119.042622","volume":"140","author":"JG Andrade","year":"2019","unstructured":"Andrade JG, Champagne J, Dubuc M, Deyell MW, Verma A, Macle L et al (2019) Cryoballoon or radiofrequency ablation for atrial fibrillation assessed by continuous monitoring: a randomized clinical trial. Circulation 140:1779\u20131788","journal-title":"Circulation"}],"container-title":["Clinical Research in Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00392-024-02401-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00392-024-02401-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00392-024-02401-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,27]],"date-time":"2025-01-27T12:53:58Z","timestamp":1737982438000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00392-024-02401-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,13]]},"references-count":12,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["2401"],"URL":"https:\/\/doi.org\/10.1007\/s00392-024-02401-w","relation":{},"ISSN":["1861-0684","1861-0692"],"issn-type":[{"type":"print","value":"1861-0684"},{"type":"electronic","value":"1861-0692"}],"subject":[],"published":{"date-parts":[[2024,3,13]]},"assertion":[{"value":"18 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the institutional review board and performed in accordance with the ethical standards as laid down in the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Daniel Steven and Arian Sultan report advisory board activities for Johnson and Johnson and have received lecture fees from Johnson and Johnson, Jakob L\u00fcker received lecture fees from Boston Scientific, and all other authors have no competing interests to declare that are relevant to the content of this article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}